anmelden
OMX Nordic 40
2.663,49
PKT
-11,82
PKT
-0,44
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 15.04.25 | Ericsson (Telefon L.M.Ericsson) (B) Sell | UBS AG | |
| 15.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 15.04.25 | Volvo (B) Outperform | RBC Capital Markets | |
| 10.04.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 10.04.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 10.04.25 | AstraZeneca Buy | UBS AG | |
| 09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 09.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 08.04.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 08.04.25 | Nokia Buy | Deutsche Bank AG | |
| 08.04.25 | Nokia Market-Perform | Bernstein Research | |
| 08.04.25 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Bernstein Research | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 04.04.25 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 03.04.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Volvo (B) Underperform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 01.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.04.25 | Volvo (B) Underperform | Bernstein Research | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. |